AMAG PHARMACEUTICALS INC.·4

Feb 26, 5:46 PM ET

Grund Nicholas 4

4 · AMAG PHARMACEUTICALS INC. · Filed Feb 26, 2019

Insider Transaction Report

Form 4
Period: 2019-02-23
Grund Nicholas
Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2019-02-23$15.51/sh982$15,23161,787 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,333 restricted stock units on February 23, 2019.

Documents

1 file
  • 4
    wf-form4_155122119573585.xmlPrimary

    FORM 4